CGI.TO
Canadian General Investments Ord
TorontoCADEQUITY
DELAYED
Last price
51.50
■ 0.00 (0.00%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
51.50
Prev close
51.50
Day high
51.50
Day low
51.50
Volume
402
Market cap
—
P/E (TTM)
—
52W range
41.31 – 54.29
Day trading desk
Gap from prior close
0.00%
Prior close 51.50
VWAP
51.50
0.00% from price
Relative volume
—
—
Session range
—
51.50 – 51.50
Position in range
—
—
ATR (14D)
0.83
1.60% of price
Prior day high
52.27
PDH
Prior day low
51.00
PDL
Bid / ask spread
—
Quote not published
Session volume
402
Shares traded
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-4.61%
-3.2%
1M
+1.18%
-2.6%
3M
-0.96%
-4.1%
6M
+3.39%
-7.7%
YTD
+8.99%
-3.3%
1Y
+28.43%
+8.4%
3Y
+46.18%
-28.0%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Free account
3 more panels on CGI.TO open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $266.55M | $321.87M | $177.69M | -$252.05M | — | -17.2% |
| Operating revenue | $266.55M | $321.87M | $177.69M | -$252.05M | — | -17.2% |
| Selling, general & admin | $2.06M | $1.90M | $1.70M | $1.23M | — | +8.5% |
| Total operating expense | $2.22M | $2.05M | $3.15M | $4.25M | — | +8.1% |
| Pre-tax income | $264.33M | $319.82M | $174.54M | -$256.29M | — | -17.3% |
| Tax provision | $5.21M | $13.24M | $382.00K | -$1.90M | — | -60.7% |
| Net income | $259.13M | $306.57M | $174.15M | -$254.39M | — | -15.5% |
| Net income to common | $259.13M | $306.57M | $174.15M | -$254.39M | — | -15.5% |
| Basic EPS | — | 14.70 | 8.35 | -12.19 | 12.21 | — |
| Diluted EPS | — | 14.70 | 8.35 | -12.19 | 12.21 | — |
| Basic shares | — | 20.86M | 20.86M | 20.87M | 20.87M | — |
| Diluted shares | 20.86M | 20.86M | 20.86M | 20.87M | — | +0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $14.16M | $35.29M | $11.18M | $3.60M | -59.9% |
| Total assets | $1.89B | $1.65B | $1.34B | $1.16B | +14.3% |
| Total debt | $200.00M | $200.00M | $175.00M | $75.00M | 0.0% |
| Total liabilities | $202.32M | $202.55M | $177.65M | $151.54M | -0.1% |
| Retained earnings | $1.55B | $1.32B | $1.03B | $877.74M | +18.0% |
| Shareholder equity | $1.68B | $1.45B | $1.16B | $1.01B | +16.4% |
| Net tangible assets | $1.68B | $1.45B | $1.16B | $1.01B | +16.4% |
| Shares issued | 20.86M | 20.86M | 20.86M | 20.86M | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $259.13M | $306.57M | $174.15M | -$254.39M | -15.5% |
| Change in working capital | -$33.00K | $78.00K | $2.68M | -$11.79M | -142.3% |
| Operating cash flow | $7.89M | $29.58M | $11.45M | $36.19M | -73.3% |
| Share buybacks | — | $0 | -$75.00M | $0 | — |
| Dividends paid | -$22.53M | -$20.86M | -$21.41M | -$22.01M | -8.0% |
| Financing cash flow | -$29.02M | -$5.47M | -$3.87M | -$49.19M | -430.4% |
| Free cash flow | $7.89M | $29.58M | $11.45M | $36.19M | -73.3% |
| End cash position | $14.16M | $35.29M | $11.18M | $3.60M | -59.9% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
| Line item | 2025-12-31 | 2025-06-30 | 2024-12-31 | YoY |
|---|---|---|---|---|
| Cash & equivalents | $14.16M | $34.96M | $35.29M | -59.5% |
| Total assets | $1.89B | $1.67B | $1.65B | +12.9% |
| Total debt | $200.00M | $200.00M | $200.00M | 0.0% |
| Total liabilities | $202.32M | $202.17M | $202.55M | +0.1% |
| Retained earnings | $1.55B | $1.34B | $1.32B | +16.0% |
| Shareholder equity | $1.68B | $1.47B | $1.45B | +14.6% |
| Net tangible assets | $1.68B | $1.47B | $1.45B | +14.6% |
| Shares issued | 20.86M | 20.86M | 20.86M | 0.0% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
52.89
-2.63% from price
SMA 20
52.31
-1.55% from price
SMA 50
52.06
-1.08% from price
SMA 100
51.53
-0.05% from price
SMA 200
49.67
+3.69% from price
EMA 12
52.41
-1.73% from price
EMA 26
52.29
-1.50% from price
EMA 50
52.04
-1.04% from price
RSI (14)
42.8
Neutral
MACD (12,26,9)
0.12
Hist -0.15
ATR (14)
0.83
1.60% of price
Realised vol 30D
15.6%
Annualised
Bollinger upper
54.24
20, 2σ
Bollinger lower
50.37
20, 2σ
50 / 200 cross
Golden
52.06 vs 49.67
Trend bias
Above 200
+3.69%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.70
Less volatile than market
Correlation to SPY
0.45
Loosely linked
Realised vol 30D
15.6%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-10.1%
Peak to trough
Max drawdown 5Y
-35.9%
Peak to trough
ATR 14
0.83
1.60% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
Industry and federally backed cancer trials diverge in goals, analysis finds
Clinical Trials Arena · 2m ago
Kaldvik AS (KLDVK): Invitation to Q2 2026 Results Webcast
GlobeNewswire · 6m ago
Visa Jumps Toward Record High as Spending Defies Walmart's Warning
GuruFocus.com · 8m ago
X-Energy's TRISO-X Unit Advances Construction of Fuel Fabrication Facility in Tennessee
MT Newswires · 8m ago
ATEX Resources Appoints Jacques Steele as Interim CFO
MT Newswires · 9m ago
New Book Contains 365 Short Daily Devotionals to Inspire Readers to Overcome Negative Experiences and Reclaim Sovereignty
PR Newswire · 9m ago
Canadian Investment Regulatory Organization Trading Halt - SABA
CNW Group · 9m ago
IceCure Signs Exclusive Distribution Agreement for ProSense® Cryoablation Systems in the Netherlands
PR Newswire · 9m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.